Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 45.04 USD -0.53% Market Closed
Market Cap: 3.7B USD
Have any thoughts about
Verona Pharma PLC?
Write Note

Balance Sheet

Balance Sheet Decomposition
Verona Pharma PLC

Current Assets 364.3m
Cash & Short-Term Investments 336m
Receivables 12.5m
Other Current Assets 15.7m
Non-Current Assets 17.6m
Long-Term Investments 15m
PP&E 2m
Intangibles 545k
Current Liabilities 28m
Accounts Payable 6.8m
Accrued Liabilities 19.1m
Other Current Liabilities 2m
Non-Current Liabilities 223.4m
Long-Term Debt 120m
Other Non-Current Liabilities 103.4m

Balance Sheet
Verona Pharma PLC

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
5
49
43
25
30
188
148
228
272
Cash Equivalents
5
49
43
25
30
188
148
228
272
Short-Term Investments
0
0
66
57
10
0
0
0
0
Total Receivables
3
1
8
7
10
8
16
9
11
Other Current Assets
0
4
2
2
4
6
6
6
7
Total Current Assets
8
54
118
91
54
203
170
243
290
PP&E Net
0
0
0
0
1
1
1
1
3
PP&E Gross
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
Intangible Assets
3
2
3
3
0
0
0
0
0
Goodwill
1
1
1
1
1
1
1
1
1
Long-Term Investments
0
0
0
0
0
0
15
15
15
Other Assets
1
1
1
1
1
1
1
1
1
Total Assets
12
N/A
57
+391%
121
+112%
95
-21%
56
-41%
204
+263%
187
-9%
260
+39%
308
+19%
Liabilities
Accounts Payable
2
1
2
4
2
0
10
3
3
Accrued Liabilities
1
3
8
6
10
12
23
14
5
Short-Term Debt
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
10
2
3
1
2
1
2
0
Total Current Liabilities
3
13
12
13
13
14
33
19
9
Long-Term Debt
0
0
0
0
0
5
5
10
48
Other Liabilities
1
1
1
1
1
1
0
0
2
Total Liabilities
4
N/A
14
+311%
13
-10%
14
+11%
14
-6%
19
+44%
39
+99%
29
-25%
59
+103%
Equity
Common Stock
2
3
7
7
7
32
32
41
43
Retained Earnings
33
33
60
77
142
207
264
333
388
Additional Paid In Capital
39
72
161
152
180
366
385
529
601
Treasury Stock
0
0
0
0
0
2
1
2
2
Other Equity
0
0
0
0
2
5
5
5
5
Total Equity
8
N/A
43
+431%
108
+154%
81
-25%
43
-47%
185
+333%
148
-20%
231
+56%
249
+8%
Total Liabilities & Equity
12
N/A
57
+391%
121
+112%
95
-21%
56
-41%
204
+263%
187
-9%
260
+39%
308
+19%
Shares Outstanding
Common Shares Outstanding
20
51
105
105
105
463
480
606
644

See Also

Discover More